Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

Share

PCI Biotech Holding ASA

Closing information (x1000 SEK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 158 More Arrow 380 More Arrow 3,231
Earnings before taxes -20,054 Less Arrow -58,245 Less Arrow -90,637
Total assets 43,484 More Arrow 67,111 More Arrow 139,433
Current assets 43,191 More Arrow 66,347 More Arrow 131,578
Current liabilities 4,910 More Arrow 6,082 More Arrow 21,441
Equity capital 38,540 More Arrow 60,684 More Arrow 116,684
- share capital 1,105 More Arrow 118,382 Less Arrow 114,824

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 88.6% More Arrow 90.4% Less Arrow 83.7%
Turnover per employee
Profit as a percentage of turnover
Return on assets (ROA) -45.8% Less Arrow -86.2% More Arrow -62.7%
Current ratio 879.7% More Arrow 1090.9% Less Arrow 613.7%
Return on equity (ROE) -52.0% Less Arrow -96.0% More Arrow -77.7%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.